S&P 500   4,998.76 (-0.25%)
DOW   37,959.42 (+0.49%)
QQQ   418.64 (-1.13%)
AAPL   165.11 (-1.16%)
MSFT   399.83 (-1.10%)
META   486.23 (-3.10%)
GOOGL   154.10 (-1.22%)
AMZN   175.79 (-1.91%)
TSLA   149.46 (-0.31%)
NVDA   818.91 (-3.28%)
AMD   151.27 (-2.46%)
NIO   3.87 (-3.25%)
BABA   68.69 (-0.28%)
T   16.38 (+0.31%)
F   12.15 (+0.75%)
MU   109.57 (-2.11%)
GE   150.87 (-1.35%)
CGC   7.79 (-0.51%)
DIS   111.77 (-0.59%)
AMC   3.11 (+6.51%)
PFE   25.54 (+0.59%)
PYPL   61.95 (-0.24%)
XOM   120.64 (+1.79%)
S&P 500   4,998.76 (-0.25%)
DOW   37,959.42 (+0.49%)
QQQ   418.64 (-1.13%)
AAPL   165.11 (-1.16%)
MSFT   399.83 (-1.10%)
META   486.23 (-3.10%)
GOOGL   154.10 (-1.22%)
AMZN   175.79 (-1.91%)
TSLA   149.46 (-0.31%)
NVDA   818.91 (-3.28%)
AMD   151.27 (-2.46%)
NIO   3.87 (-3.25%)
BABA   68.69 (-0.28%)
T   16.38 (+0.31%)
F   12.15 (+0.75%)
MU   109.57 (-2.11%)
GE   150.87 (-1.35%)
CGC   7.79 (-0.51%)
DIS   111.77 (-0.59%)
AMC   3.11 (+6.51%)
PFE   25.54 (+0.59%)
PYPL   61.95 (-0.24%)
XOM   120.64 (+1.79%)
S&P 500   4,998.76 (-0.25%)
DOW   37,959.42 (+0.49%)
QQQ   418.64 (-1.13%)
AAPL   165.11 (-1.16%)
MSFT   399.83 (-1.10%)
META   486.23 (-3.10%)
GOOGL   154.10 (-1.22%)
AMZN   175.79 (-1.91%)
TSLA   149.46 (-0.31%)
NVDA   818.91 (-3.28%)
AMD   151.27 (-2.46%)
NIO   3.87 (-3.25%)
BABA   68.69 (-0.28%)
T   16.38 (+0.31%)
F   12.15 (+0.75%)
MU   109.57 (-2.11%)
GE   150.87 (-1.35%)
CGC   7.79 (-0.51%)
DIS   111.77 (-0.59%)
AMC   3.11 (+6.51%)
PFE   25.54 (+0.59%)
PYPL   61.95 (-0.24%)
XOM   120.64 (+1.79%)
S&P 500   4,998.76 (-0.25%)
DOW   37,959.42 (+0.49%)
QQQ   418.64 (-1.13%)
AAPL   165.11 (-1.16%)
MSFT   399.83 (-1.10%)
META   486.23 (-3.10%)
GOOGL   154.10 (-1.22%)
AMZN   175.79 (-1.91%)
TSLA   149.46 (-0.31%)
NVDA   818.91 (-3.28%)
AMD   151.27 (-2.46%)
NIO   3.87 (-3.25%)
BABA   68.69 (-0.28%)
T   16.38 (+0.31%)
F   12.15 (+0.75%)
MU   109.57 (-2.11%)
GE   150.87 (-1.35%)
CGC   7.79 (-0.51%)
DIS   111.77 (-0.59%)
AMC   3.11 (+6.51%)
PFE   25.54 (+0.59%)
PYPL   61.95 (-0.24%)
XOM   120.64 (+1.79%)
Free Trial

West Pharmaceutical Services (WST) Earnings Date, Estimates & Call Transcripts

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)
Free wst Stock Alerts
$375.94
-1.39 (-0.37%)
(As of 10:24 AM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability

Earnings Summary

Upcoming
Earnings Date
Apr. 25
Before Market Opens
Confirmed
Actual EPS
(Feb. 15)
$1.83 Beat By $0.05
Consensus EPS
(Feb. 15)
$1.78
Read Call Transcript
Listen to Call
Latest SEC 10-Q Filing
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

WST Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

WST Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

West Pharmaceutical Services Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20243$1.30$2.05$1.55 
Q2 20243$1.97$2.28$2.10 
Q3 20243$2.11$2.35$2.19 
Q4 20243$2.15$2.24$2.19 
FY 202412$7.53$8.92$8.02 
Q1 20251$1.86$1.86$1.86 
Q2 20251$2.27$2.27$2.27 
Q3 20251$2.44$2.44$2.44 
Q4 20251$2.44$2.44$2.44 
FY 20254$9.01$9.01$9.01 
Q1 20261$2.16$2.16$2.16 

WST Earnings Date and Information

West Pharmaceutical Services last announced its quarterly earnings data on February 15th, 2024. The medical instruments supplier reported $1.83 EPS for the quarter, topping the consensus estimate of $1.78 by $0.05. The firm earned $732 million during the quarter, compared to analyst estimates of $740.43 million. Its revenue for the quarter was up 3.3% compared to the same quarter last year. West Pharmaceutical Services has generated $7.88 earnings per share over the last year ($7.88 diluted earnings per share) and currently has a price-to-earnings ratio of 47.7. Earnings for West Pharmaceutical Services are expected to grow by 19.69% in the coming year, from $7.62 to $9.12 per share. West Pharmaceutical Services has confirmed that its next quarterly earnings report will be published on Thursday, April 25th, 2024. West Pharmaceutical Services will be holding an earnings conference call on Thursday, April 25th at 9:00 AM Eastern. Interested parties can register for or listen to the call..

West Pharmaceutical Services Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
4/25/2024
Confirmed)		-------  
2/15/2024Q4 2023$1.78$1.83+$0.05$1.83$740.43 million$732.00 million      
10/26/2023Q3 2023$1.86$2.16+$0.30$2.18$750.31 million$747.40 million      
7/27/2023Q2 2023$1.95$2.11+$0.16$2.16$755.71 million$753.80 million    
4/27/2023Q1 2023$1.67$1.98+$0.31$2.11$697.28 million$716.60 million    
2/16/2023Q4 2022$1.39$1.77+$0.38$2.18$657.16 million$708.70 million    
10/27/2022Q3 2022$2.12$2.03($0.09)$2.47$730.64 million$686.90 million
7/28/2022Q2 2022$2.19$2.47+$0.28$2.46$754.25 million$771.30 million    
4/28/2022Q1 2022$2.18$2.30+$0.12$2.31$720.92 million$720.00 million    
2/17/2022Q4 2021$1.92$2.04+$0.12$2.15$710.20 million$730.80 million    
10/28/2021Q3 2021$1.80$2.06+$0.26$1.81$687.09 million$706.50 million    
7/29/2021Q2 2021$1.74$2.46+$0.72$2.45$665.55 million$723.60 million      
4/29/2021Q1 2021$1.42$2.05+$0.63$2.11$614.77 million$670.70 million  

West Pharmaceutical Services Earnings - Frequently Asked Questions

When is West Pharmaceutical Services's earnings date?

West Pharmaceutical Services has confirmed that its next quarterly earnings data will be published on Thursday, April 25th, 2024. Learn more on WST's earnings history.

Did West Pharmaceutical Services beat their earnings estimates last quarter?

In the previous quarter, West Pharmaceutical Services (NYSE:WST) reported $1.83 earnings per share (EPS) to beat the analysts' consensus estimate of $1.78 by $0.05. Learn more on analysts' earnings estimate vs. WST's actual earnings.

How can I listen to West Pharmaceutical Services's earnings conference call?

The conference call for West Pharmaceutical Services's latest earnings report can be listened to online. Listen to Conference Call

How can I read West Pharmaceutical Services's conference call transcript?

The conference call transcript for West Pharmaceutical Services's latest earnings report can be read online. Read Transcript

How can I view West Pharmaceutical Services's earnings report?

West Pharmaceutical Services's earnings report can be found in their filing with the SEC. View SEC filing

How much revenue does West Pharmaceutical Services generate each year?

West Pharmaceutical Services (NYSE:WST) has a recorded annual revenue of $2.95 billion.

How much profit does West Pharmaceutical Services generate each year?

West Pharmaceutical Services (NYSE:WST) has a recorded net income of $593.40 million. WST has generated $7.88 earnings per share over the last four quarters.

What is West Pharmaceutical Services's price-to-earnings ratio?

West Pharmaceutical Services (NYSE:WST) has a trailing price-to-earnings ratio of 47.71 and a forward price-to-earnings ratio of 49.34. The price/earnings-to-growth ratio is 6.45.

What is West Pharmaceutical Services's EPS forecast for next year?

West Pharmaceutical Services's earnings are expected to grow from $7.62 per share to $9.12 per share in the next year, which is a 19.69% increase.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NYSE:WST) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Biden’s $374B Giveaway Into This Sector
DTI
The #1 Crypto for 2024
InvestorPlace
He Is Giving Away Bitcoin
Crypto Swap Profits
How Biden has already won 2024
Porter & Company
Urgent alert: open this for a huge profit potential
Timothy Sykes
My biggest AI fear
Paradigm Press